Abstract Details
|
Nisha S. Bhatia, MD
(Highland Hospital)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Henrik Zetterberg (Sahlgrenska University Hospital/Molndal) | Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions. |
| No disclosure on file | |
| No disclosure on file | |
| Richard W. Price, MD, FAAN (San Francisco General Hospital) | No disclosure on file |
| Serena Spudich, MD (Yale University) | The institution of Dr. Spudich has received research support from NIH. |